Basic Information
20Med Therapeutics is a Dutch biotechnology company focused on developing preventive and therapeutic vaccines. Based on its proprietary bio-responsive polymer nanoparticle technology, 20Med is building a non-viral delivery platform for the rapid development of RNA- and DNA-based vaccines, applicable to infectious diseases and cancer.
20Med Therapeutics
Enschede,Overijssel,Netherlands
less than 15 people
--
Info@20medtx.com
Enterprise Profile
Industrial Sector
Technology
Concept
Application Scenarios